David W. Oslin

Psychiatry
3400 Spruce St
Philadelphia, PA 19104

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 166 publications

GLP-1 Receptor Agonists and All-Cause Overdose Risk in Veterans With Type 2 Diabetes and Opioid Use Disorder.

GLP-1 Receptor Agonists and All-Cause Overdose Risk in Veterans With Type 2 Diabetes and Opioid Use Disorder.

Journal: The Journal of clinical psychiatry
Published: July 20, 2026

Evaluating the acceptability, feasibility, and appropriateness of treatment engagement strategies for primary care patients at risk for suicide: a pilot study.

Evaluating the acceptability, feasibility, and appropriateness of treatment engagement strategies for primary care patients at risk for suicide: a pilot study.

Journal: Frontiers in psychiatry
Published: June 01, 2026

Persistent benefit of pharmacogenomic testing on initial remission and response rates in patients with major depressive disorder.

Persistent benefit of pharmacogenomic testing on initial remission and response rates in patients with major depressive disorder.

Journal: Frontiers in pharmacology
Published: July 02, 2025

What Psychiatric Services Stands For.

What Psychiatric Services Stands For.

Journal: Psychiatric services (Washington, D.C.)
Published: April 30, 2025

The Perceived Value of Pharmacogenetic Testing in Depression Treatment: Mixed-Methods Results From the PRIME Care Study.

The Perceived Value of Pharmacogenetic Testing in Depression Treatment: Mixed-Methods Results From the PRIME Care Study.

Journal: Psychiatric services (Washington, D.C.)
Published: April 16, 2025

Electrographic cue-reactivity co-localizes with accumbens deep brain stimulation in a case of opioid use disorder.

Electrographic cue-reactivity co-localizes with accumbens deep brain stimulation in a case of opioid use disorder.

Journal: Nature communications
Published: March 11, 2025

A Randomized Controlled Trial of Cognitive Behavioral Therapy for Insomnia During Early Recovery from Alcohol Use Disorder Among Veterans.

A Randomized Controlled Trial of Cognitive Behavioral Therapy for Insomnia During Early Recovery from Alcohol Use Disorder Among Veterans.

Journal: medRxiv : the preprint server for health sciences
Published: January 13, 2025

What if STAR*D Had Been Placebo-Controlled? A Critical Reexamination of a Foundational Study in Depression Treatment.

What if STAR*D Had Been Placebo-Controlled? A Critical Reexamination of a Foundational Study in Depression Treatment.

Journal: Journal of clinical psychopharmacology
Published: January 07, 2025

Macrophage Migration Inhibitory Factor and Interleukin 1-β mRNA Levels as Predictors of Antidepressant Treatment Response in Major Depression.

Macrophage Migration Inhibitory Factor and Interleukin 1-β mRNA Levels as Predictors of Antidepressant Treatment Response in Major Depression.

Journal: Psychopharmacology bulletin
Published: January 02, 2025

A pilot study of pharmacogenomic testing as a tool to enhance depression care in Veterans.

A pilot study of pharmacogenomic testing as a tool to enhance depression care in Veterans.

Journal: The pharmacogenomics journal
Published: October 14, 2024

Providers' use of pharmacogenetic testing to inform opioid prescribing among veterans.

Providers' use of pharmacogenetic testing to inform opioid prescribing among veterans.

Journal: Pharmacogenomics
Published: October 09, 2024

Concerns about genetic risk testing for opioid use disorder.

Concerns about genetic risk testing for opioid use disorder.

Journal: The lancet. Psychiatry
Published: August 23, 2024
Showing 1-12 of 166

Last Updated: 09/26/2026